CD4+ and CD8+ T-cell skewness in classic Kaposi sarcoma

Neoplasia (United States)

Volumn 14, Issue 6, 2012, Pages 487-494

  Galleu, Antonio ^a   Fozza, Claudio ^a   Simula, Maria Pina ^a   Contini, Salvatore ^a   Virdis, Patrizia ^a   Corda, Giovanna ^a   Pardini, Simonetta ^a   Cottoni, Francesca ^a   Pruneddu, Sara ^a   Angeloni, Antonio ^b   Ceccarelli, Simona ^b   Longinotti, Maurizio ^a  

^a UNIVERSITY OF SASSARI   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR BETA CHAIN;

ADULT; AGED; ALLELE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL SEPARATION; CLINICAL ARTICLE; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE AMPLIFICATION; GENOTYPE; HUMAN; HUMAN HERPESVIRUS 8; IMMUNE SYSTEM; IMMUNOFLUORESCENCE; KAPOSI SARCOMA; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION MAPPING; SERODIAGNOSIS; SPECTRATYPING;

EID: 84865654457     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1596/neo.11646     Document Type: Article

References (38)

1. Hengge UR, Ruzicka T, Tyring SK, Stuschke M, Roggendorf M, Schwartz RA, and Seeber S (2002). Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: Epidemiology, environmental predispositions, clinical manifestations, and therapy. Lancet Infect Dis 2, 281-292.
2. Ensoli B, Sgadari C, Barillari G, Sirianni MC, Sturzl M, and Monini P (2001). Biology of Kaposi's sarcoma. Eur J Cancer 37, 1251-1269.
3. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, and Moore PS (1994). Identification of herpesvirus-like DNA sequences in AIDSassociated Kaposi's sarcoma. Science 266, 1865-1869.
4. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans: human immunodeficiency viruses and human T-cell lymphotropic viruses. Lyon, France, 1-18 June 1996. (1996). IARC Monogr Eval Carcinog Risks Hum 67, 1-424.
5. Cottoni F, Masala MV, Pattaro C, Pirodda C, Montesu MA, Satta R, Cerimele D, and de Marco R (2006). Classic Kaposi sarcoma in northern Sardinia: a prospective epidemiologic overview (1977-2003) correlated with malaria prevalence (1934). J Am Acad Dermatol 55, 990-995.
6. Sirianni MC, Vincenzi L, Fiorelli V, Topino S, Scala E, Uccini S, Angeloni A, Faggioni A, Cerimele D, Cottoni F, et al. (1998). gamma-Interferon production in peripheral blood mononuclear cells and tumor infiltrating lymphocytes from Kaposi's sarcoma patients: correlation with the presence of human herpesvirus-8 in peripheral blood mononuclear cells and lesional macrophages. Blood 91, 968-976.
7. Fiorelli V, Gendelman R, Samaniego F, Markham PD, and Ensoli B (1995). Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells. J Clin Invest 95, 1723-1734.
8. Samaniego F, Markham PD, Gendelman R, Watanabe Y, Kao V, Kowalski K, Sonnabend JA, Pintus A, Gallo RC, and Ensoli B (1998). Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development. Am J Pathol 152, 1433-1443.
9. Monini P, Colombini S, Sturzl M, Goletti D, Cafaro A, Sgadari C, Butto S, Franco M, Leone P, Fais S, et al. (1999). Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma. Blood 93, 4044-4058.
10. Cattelan AM, Calabro ML, Aversa SM, Zanchetta M, Meneghetti F, De Rossi A, and Chieco-Bianchi L (1999). Regression of AIDS-related Kaposi's sarcoma following antiretroviral therapy with protease inhibitors: biological correlates of clinical outcome. Eur J Cancer 35, 1809-1815.
11. Nagy S, Gyulai R, Kemeny L, Szenohradszky P, and Dobozy A (2000). Iatrogenic Kaposi's sarcoma: HHV8 positivity persists but the tumors regress almost completely without immunosuppressive therapy. Transplantation 69, 2230-2231.
12. Barozzi P, Bonini C, Potenza L, Masetti M, Cappelli G, Gruarin P, Whitby D, Gerunda GE, Mondino A, Riva G, et al. (2008). Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma. Transplantation 86, 738-744.
13. Brown EE, Whitby D, Vitale F, Marshall V, Mbisa G, Gamache C, Lauria C, Alberg AJ, Serraino D, Cordiali-Fei P, et al. (2006). Virologic, hematologic, and immunologic risk factors for classic Kaposi sarcoma. Cancer 107, 2282-2290.
14. Pellet C, Kerob D, Dupuy A, Carmagnat MV, Mourah S, Podgorniak MP, Toledano C, Morel P, Verola O, Dosquet C, et al. (2006). Kaposi's sarcomaassociated herpesvirus viremia is associated with the progression of classic and endemic Kaposi's sarcoma. J Invest Dermatol 126, 621-627.
15. Turner SJ, Doherty PC, McCluskey J, and Rossjohn J (2006). Structural determinants of T-cell receptor bias in immunity. Nat Rev Immunol 6, 883-894.
16. van den Beemd R, Boor PP, van Lochem EG, Hop WC, Langerak AW, Wolvers-Tettero IL, Hooijkaas H, and van Dongen JJ (2000). Flow cytometric analysis of the Vβ repertoire in healthy controls. Cytometry 40, 336-345.
17. Gorski J, Yassai M, Zhu X, Kissela B, Kissella B, Keever C, and Flomenberg N (1994). Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping. Correlation with immune status. J Immunol 152, 5109-5119.
18. Bonfigli S, Fozza C, Contini S, Buzzetti R, Cucca F, and Longinotti M (2007). High frequency of the TCRBV20S1 null allele in the Sardinian population. Hum Immunol 68, 426-429.
19. Bonfigli S, Doro MG, Fozza C, Derudas D, Dore F, and Longinotti M (2003). T-cell receptor repertoire in healthy Sardinian subjects. Hum Immunol 64, 689-695.
20. Stratigos AJ, Malanos D, Touloumi G, Antoniou A, Potouridou I, Polydorou D, Katsambas AD, Whitby D, Mueller N, Stratigos JD, et al. (2005). Association of clinical progression in classic Kaposi's sarcoma with reduction of peripheral B lymphocytes and partial increase in serum immune activation markers. Arch Dermatol 141, 1421-1426.
21. Mitsuyasu RT and Groopman JE (1984). Biology and therapy of Kaposi's sarcoma. Semin Oncol 11, 53-59.
22. Santarelli R, De Marco R, Masala MV, Angeloni A, Uccini S, Pacchiarotti R, Montesu MA, Satta R, Cerimele D, Faggioni A, et al. (2001). Direct correlation between human herpesvirus-8 seroprevalence and classic Kaposi's sarcoma incidence in Northern Sardinia. J Med Virol 65, 368-372.
23. Chomczynski P and Sacchi N (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162, 156-159.
24. Chen X, Barfield R, Benaim E, Leung W, Knowles J, Lawrence D, Otto M, Shurtleff SA, Neale GA, Behm FG, et al. (2005). Prediction of T-cell reconstitution by assessment of T-cell receptor excision circle before allogeneic hematopoietic stem cell transplantation in pediatric patients. Blood 105, 886-893.
25. Lu J, Basu A, Melenhorst JJ, Young NS, and Brown KE (2004). Analysis of T-cell repertoire in hepatitis-associated aplastic anemia. Blood 103, 4588-4593.
26. Charmley P, Wang K, Hood L, and Nickerson DA (1993). Identification and physical mapping of a polymorphic human T cell receptor V β gene with a frequent null allele. J Exp Med 177, 135-143.
27. Lambert M, Gannage M, Karras A, Abel M, Legendre C, Kerob D, Agbalika F, Girard PM, Lebbe C, and Caillat-Zucman S (2006). Differences in the frequency and function of HHV8-specific CD8 T cells between asymptomatic HHV8 infection and Kaposi sarcoma. Blood 108, 3871-3880.
28. Guihot A, Dupin N, Marcelin AG, Gorin I, Bedin AS, Bossi P, Galicier L, Oksenhendler E, Autran B, and Carcelain G (2006). Low T cell responses to human herpesvirus 8 in patients with AIDS-related and classic Kaposi sarcoma. J Infect Dis 194, 1078-1088.
29. +) T-cell epitope for the glycoprotein B homolog of human herpesvirus 8. Blood 99, 3360-3366.
30. Stebbing J, Bourboulia D, Johnson M, Henderson S, Williams I, Wilder N, Tyrer M, Youle M, Imami N, Kobu T, et al. (2003). Kaposi's sarcoma-associated herpesvirus cytotoxic T lymphocytes recognize and target Darwinian positively selected autologous K1 epitopes. J Virol 77, 4306-4314.
31. Miqueu P, Guillet M, Degauque N, Dore JC, Soulillou JP, and Brouard S (2007). Statistical analysis of CDR3 length distributions for the assessment of T and B cell repertoire biases. Mol Immunol 44, 1057-1064.
32. Alaibac M, Congedo M, Barbarossa G, Bottiglieri A, Fillippi ED, Marzullo F, Quarta G, and Schittulli F (1997). Analysis of clonal antigen receptor gene rearrangements in T-cells involved with Kaposi's sarcoma. Anticancer Res 17, 1205-1207.
33. Fozza C, Contini S, Galleu A, Simula MP, Virdis P, Bonfigli S, and Longinotti M (2009). Patients with myelodysplastic syndromes display several T-cell expansions, which are mostly polyclonal in the CD4(+) subset and oligoclonal in the CD8(+) subset. Exp Hematol 37, 947-955.
34. Risitano AM, Kook H, Zeng W, Chen G, Young NS, and Maciejewski JP (2002). Oligoclonal and polyclonal CD4 and CD8 lymphocytes in aplastic anemia and paroxysmal nocturnal hemoglobinuria measured by V β CDR3 spectratyping and flow cytometry. Blood 100, 178-183.
35. Arons E, Sorbara L, Raffeld M, Stetler-Stevenson M, Steinberg SM, Liewehr DJ, Pastan I, and Kreitman RJ (2006). Characterization of T-cell repertoire in hairy cell leukemia patients before and after recombinant immunotoxin BL22 therapy. Cancer Immunol Immunother 55, 1100-1110.
36. Correia-Neves M, Waltzinger C, Mathis D, and Benoist C (2001). The shaping of the T cell repertoire. Immunity 14, 21-32.
37. Trautmann L, Rimbert M, Echasserieau K, Saulquin X, Neveu B, Dechanet J, Cerundolo V, and Bonneville M (2005). Selection of T cell clones expressing high-affinity public TCRs within human cytomegalovirus-specific CD8 T cell responses. J Immunol 175, 6123-6132.
38. Wynn KK, Crough T, Campbell S, McNeil K, Galbraith A, Moss DJ, Silins SL, Bell S, and Khanna R (2010). Narrowing of T-cell receptor β variable repertoire during symptomatic herpesvirus infection in transplant patients. Immunol Cell Biol 88, 125-135.